Oc.07.7: sustained improvement in inflammatory bowel disease questionnaire outcomes in moderately to severely active ulcerative colitis with continued mirikizumab treatment in phase 3 lucent-3 study

B.E. Sands,B.G. Feagan, A. Armuzzi, K. Mcginnis, K. Lynch,T. Hunter Gibble, J. Johns,C.A. Siegel,V. Jairath, J. Asaro

Digestive and Liver Disease(2024)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要